Belgium· BE-AMP-SAM585804-00
Xerava 100 mg
A eravacycline product containing eravacycline, registered in Belgium by Paion Pharma. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eravacycline is registered in 11 of 19 countries.
Countries holding a registration under ATC J01AA13 (eravacycline), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Eravacycline · ATC J01AA13
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eravacycline
- Manufacturer
- Paion Pharma
- Country
- Belgium (BE)
- ATC code
- J01AA13
- ATC class
- Eravacycline
- Defined daily dose
- 0.14 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4733895
- be_apb7739477
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for eravacycline.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eravacycline · interactions on record
31 records
- 11 severe
- 11 moderate
- 9 minor
Most severe, free to view
- AcitretinD05BB02severe
- IsotretinoinD10AD04severe
- IsotretinoinD10BA01severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eravacycline in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaXERAVAPAION Pharma GmbH, Aachen
- SpainXERAVA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- FinlandXeravaPAION Pharma GmbH
- United KingdomXerava 100mg powder for concentrate for solution for infusion vialsPAION Pharma GmbH
- IrelandXerava 100 mg Powder for concentrate for solution for infusionPaion Pharma GmbH
- IcelandXeravaPAION Pharma GmbH
- PolandXeravaPAION Pharma GmbH
- SwedenXerava 100 mg Pulver till koncentrat till infusionsvätska, lösningPAION Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Xerava
- Liechtenstein · Xerava
- Norway · Xerava
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1b7a36c8-d451-4905-b604-40acafb2c992 GET /v1/drugs/1b7a36c8-d451-4905-b604-40acafb2c992?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Xerava 100 mg",
"name_fr": "Xerava 100 mg",
"name_nl": "Xerava 100 mg",
"amp_code": "SAM585804-00",
"strengths": [
"100.0000",
"100.0000",
"100.0000"
],
"pack_count": 3,
"substances": [
"Eravacycline",
"Mannitol",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Eravacycline",
"authorisation_numbers": [
"EU/1/18/1312/004",
"EU/1/18/1312/003",
"EU/1/18/1312/005"
]
}See everything about eravacycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.